Heather Parnell
Women's Health · Bowling Green, KYNPI 1063684819
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,694 of the $5,225 with a category attached, or 89.8%. It is spread thinly across 33 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,576 and has fallen 60.4% since, to $625 in 2025. Among women's health clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aspira Women's Health Inc$896
- AbbVie$730
- Astellas Pharma US Inc$714
- Biogen$368
- Mayne Pharma Commercial LLC$346
- Exeltis, USA Inc.$301
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,69490%
- Education$53110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aspira Women's Health Inc | 20 | $896 |
| AbbVie | 44 | $730 |
| Astellas Pharma US Inc | 15 | $714 |
| Biogen | 21 | $368 |
| Mayne Pharma Commercial LLC | 19 | $346 |
| Exeltis, USA Inc. | 19 | $301 |
| Shield Therapeutics Inc | 8 | $251 |
| Organon | 14 | $247 |
| Novo Nordisk | 10 | $157 |
| Sumitomo Pharma America, Inc. | 9 | $151 |
| Pfizer | 10 | $144 |
| Daiichi Sankyo Inc. | 6 | $133 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $96 |
| Myovant Sciences Inc. | 6 | $89 |
| Bayer | 6 | $83 |
| Millicent US Inc | 4 | $66 |
| Amgen | 3 | $50 |
| Hologic Sales And Service, LLC | 3 | $45 |
| Baxter Healthcare | 1 | $36 |
| Exact Sciences | 2 | $35 |
| Channel Medsystems, Inc. | 1 | $34 |
| AstraZeneca | 1 | $32 |
| Agile Therapeutics, Inc. | 2 | $32 |
| Evofem Biosciences, Inc. | 2 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Vertex | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Axonics, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Merck | 1 | $12 |
How this compares
$5,225 in reported general payments places this provider in the 95th percentile of 96 women's health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 24 | $14,786 |
| PremarinEstrogens, Conjugated | 26 | $8,037 |
| Estradiol | 111 | $7,582 |
| Estradiol (Twice Weekly)Estradiol | 14 | $1,829 |
| ProgesteroneProgesterone, Micronized | 48 | $1,514 |
| Clobetasol Propionate | 15 | $686 |
| ValacyclovirValacyclovir Hcl | 15 | $622 |
| Fluconazole | 21 | $213 |
| Norethindrone | 18 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $714 | $14,78624 claims |
| PfizerPremarin | $144 | $8,03726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 96 women's health providers in Kentucky.
Other women's health in Bowling Green
- Mincha ParkerLexington$8K
- Alicia KrummenFlorence$4K
- Jeannette JaggersLouisville$4K
- Taneka LindsayLouisville$3K
- Carrie ThonenLouisville$3K
- Megan HillWilliamsburg$2K
- Sherry GuilerNicholasville$2K
- Sarah LucasAshland$2K
- Janice EklundLouisville$2K
- Juanita HouseSomerset$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.